Ein Unternehmen der RHÖN-KLINIKUM AG

Aktuell laufende Studien

"Deutsche prospektive Registerstudie zur Erfassung der Behandlungspraxis von gynäkologischen
Sarkomen in der klinischen Routine. "
An EPidEmiological, PRospective Cohort Study to Generate Real-world Evidence in Patients With HR+/HER2- Advanced Breast Cancer Treated in the First-line Setting as per Current Standard Of Care With an EndocRine-based Palbociclib CoMbination Therapy
"Pelvic and Para-aortic Lymphadenectomy in Patients with Stage I or II Endometrial Cancer with High Risk of Recurrence
A Multicenter, Prospective Randomized Controlled Trial"
Prevention of paclitaxel-related neurological side effects with lithium – a randomized, double-blind, placebo-controlled, explorative proof-of-concept phase II clinical trial to counteract chemotherapy induced neurotoxicity
Qualitätssicherung der Therapie des Ovarialkarzinoms
AGO Studiengruppe
Aktuell in Vorbereitung:
 PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan (PROVIDENCE)